Empirical Analysis of Cultivating New Quality Productivity of Biomedical Industry with mRNA Technology——Taking Zhejiang Province as an Example

OBJECTIVE  To explore how Zhejiang province can cultivate new quality productivity in the biomedical industry using mRNA technology, enhance industrial competitiveness, and narrow the gap with the leading regions worldwide.

METHODS Through literature research, patent analysis, and on-the-spot investigation, comprehensively evaluated the scientific research strength, innovation platform, and industrialization foundation in the mRNA field in Zhejiang province. Identified the main challenges regarding technical barriers, shortage of funds, insufficient industrial chain coordination, and lagging regulatory approval.

RESULTS  Zhejiang province had a certain degree of foundation in mRNA research and industrialization. However, compared with the advanced international peers, there were still some problems, such as insufficient key technology reserves, complex financing, weak industrial chain coordination, and low efficiency of supervision and approval. The countermeasures included strengthening the research and development of critical technologies, optimizing the allocation of funds and human resources, promoting in-depth cooperation between industry and academy research, and improving the policy environment.

CONCLUSION Zhejiang province needs to strengthen mRNA technology to tackle fundamental research problems, improve the efficiency of resource allocation, deepen industrial cooperation, and optimize policy support to accelerate the transformation and application of mRNA technology, cultivate new industrial kinetic energy, enhance overall competitiveness, and form new quality productivity of biomedical industry with global influence.